Doctor Mika Lehto
Helsinki University Hospital, Helsinki (Finland)
Membership:
ESC Professional Member
EHRA Member
Follow
Contributor content
Presentation
Hypo- and hyperthyroidism in patients with new-onset atrial fibrillation: a nationwide study
Presentation
Presentation
Quo vadis, the leading arrhythmia? Projecting the prevalence of atrial fibrillation up to 2070
Presentation
Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study
Presentation
How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.
Presentation
Presentation
Presentation
